BSE · 542650 · Healthcare
Metropolis Healthcare Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹417 Cr with net profit ₹69 Cr — a 16.49% net margin, versus 13.59% the period before.
Shareholding
As of 2026-09-30
- Promoter47.82%
- Public5.02%
- FII11.67%
- DII35.49%
50,592 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.47× from low to high.
Risk flags
Derived from disclosed data
- Promoter holding fell 1.04 percentage points to 47.82% in the latest disclosure.
Peer comparison
Healthcare · ranked #15 of 87 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,22,591 Cr | 54.13 | 11.55 | 21.14% | 8.12% |
| Max Healthcare Institute Ltd. | ₹92,184 Cr | 64.91 | 8.12 | 12.18% | 15.1% |
| Manipal Health Enterpri Limited | ₹89,630 Cr | 95.57 | 5.44 | 10.59% | 6.87% |
| Aster DM Quality Care Ltd. | ₹62,952 Cr | 113.55 | 8.46 | 7.11% | 7.23% |
| Fortis Healthcare Ltd. | ₹57,679 Cr | 53.73 | 5.51 | 9.91% | 10.48% |
| Global Health Limited | ₹39,095 Cr | 60.38 | 9.04 | 14.3% | 12.24% |
| Narayana Hrudayalaya Ltd. | ₹38,019 Cr | 42.01 | 7.61 | 17.17% | 8.36% |
| Dr. Lal Path Labs Ltd. | ₹33,452 Cr | 55.22 | 12.18 | 21.32% | 19.29% |
| Krishna Institute of Medical Sciences Ltd. | ₹30,646 Cr | 150.75 | 7.79 | 5.4% | 4.62% |
| Dr. Agarwal's Health Care Limited | ₹17,463 Cr | 97.66 | 7.81 | 8.04% | 7.61% |
| Metropolis Healthcare Limited(this company) | ₹11,696 Cr | 50.64 | 7.13 | 13.66% | 12.62% |
AI analysis
AI-generated · google/gemini-2.5-flashMetropolis Healthcare Limited (symbol: 542650) operates in the Healthcare sector with a market capitalization of Rs 11786 Cr. The company reported a revenue growth of 10.23% and a profit margin of 11.55%.
Positives
- +The institutional shareholding is significant at 46.22% as of March 31, 2026.
- +The debt-to-equity ratio is relatively low at 0.17, indicating prudent financial management.
- +The company reported a positive revenue growth of 10.23%.
Negatives
- −The promoter holding has decreased from 57.41% on April 28, 2019, to 48.87% on March 31, 2026.
- −There is a promoter pledge of 1.18% of shares as of March 31, 2026.
- −The company's dividend yield is high at 88%, which may warrant further investigation into its sustainability or potential special payouts.
Financial Performance
Metropolis Healthcare Limited has shown revenue growth of 10.23%. The company's latest annual revenue was Rs 1645.85 Cr and net profit was Rs 190.02 Cr for the period ending March 2026. Quarterly revenue for March 2026 was Rs 424.68 Cr, with a net profit of Rs 50.9 Cr.
Profitability & Returns
The company's profit margin stands at 11.55%. Return on Equity (ROE) is 12.56%, and Return on Capital Employed (ROCE) is 16.245%. The Earnings Per Share (EPS) is Rs 9.48.
Balance Sheet
Metropolis Healthcare Limited has a debt-to-equity ratio of 0.17. The book value per share is Rs 72.98. Further details on assets and liabilities are not provided in the available data.
Ownership & Pledges
As of March 31, 2026, promoter holding was 48.8656%. Institutional holding (DII and FII combined) was 46.2208%, with DIIs holding 35.7944% and FIIs holding 10.4264%. Public shareholding was 4.9136%. A promoter pledge of 1.18% exists.
Data as of — price: 2026-11-14 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Metropolis Healthcare Limitedshare price & fundamentals